George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

In 2017, the Philippine National Police claimed that the war on drugs had led to the surrender of nearly 90,000 “drug pushers” to the authorities and a 26.45 percent reduction in the size of ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...

During Duterte’s six-year presidential term, government data reported around 6,000 drug-related killings. Human rights groups, however, peg the number much higher, estimating that up to 30,000 ...

The company announced FDA that the U.S. Food and Drug Administration has approved LungFit PH to treat term and near-term neonates with hypoxic respiratory failure, often referred to as persistent ...

The Company has received FDA approval and CE Mark for its first system, LungFit® PH, for the treatment of term and near-term neonates with hypoxic respiratory failure.

WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the ...